Results 1 to 10 of about 2,474,660 (311)

Inhibition of the lectin pathway of complement activation reduces LPS-induced acute respiratory distress syndrome in mice [PDF]

open access: yesFrontiers in Immunology, 2023
Acute respiratory distress syndrome (ARDS) is a life-threatening disorder with a high rate of mortality. Complement activation in ARDS initiates a robust inflammatory reaction that can cause progressive endothelial injury in the lung.
Youssif M. Ali   +11 more
doaj   +3 more sources

Development and characterization of narsoplimab, a selective MASP-2 inhibitor, for the treatment of lectin-pathway–mediated disorders [PDF]

open access: yesFrontiers in Immunology, 2023
IntroductionOveractivation of the lectin pathway of complement plays a pathogenic role in a broad range of immune-mediated and inflammatory disorders; mannan-binding lectin-associated serine protease-2 (MASP-2) is the key effector enzyme of the lectin ...
Thomas Dudler   +2 more
doaj   +3 more sources

Complement lectin pathway activation is associated with COVID-19 disease severity, independent of MBL2 genotype subgroups [PDF]

open access: yesFrontiers in Immunology, 2023
IntroductionWhile complement is a contributor to disease severity in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, all three complement pathways might be activated by the virus.
Lisa Hurler   +174 more
doaj   +3 more sources

Dengue and the Lectin Pathway of the Complement System. [PDF]

open access: yesViruses, 2021
Dengue is a mosquito-borne viral disease causing significant health and economic burdens globally. The dengue virus (DENV) comprises four serotypes (DENV1-4).
Kraivong R   +4 more
europepmc   +7 more sources

Plasma Lectin Pathway Complement Proteins in Patients With COVID-19 and Renal Disease [PDF]

open access: yesFrontiers in Immunology, 2021
We do not understand why non-white ethnicity and chronic kidney disease increase susceptibility to COVID-19. The lectin pathway of complement activation is a key contributor to innate immunity and inflammation.
Nicholas R. Medjeral-Thomas   +23 more
doaj   +3 more sources

Role of the lectin pathway of complement in hematopoietic stem cell transplantation-associated endothelial injury and thrombotic microangiopathy [PDF]

open access: yesExperimental Hematology & Oncology, 2021
Hematopoietic stem cell transplantation-associated thrombotic microangiopathy (HSCT-TMA) is a life-threatening syndrome that occurs in adult and pediatric patients after hematopoietic stem cell transplantation.
Eleni Gavriilaki   +6 more
doaj   +3 more sources

Components of the Lectin Pathway of Complement in Haematologic Malignancies. [PDF]

open access: yesCancers (Basel), 2020
The complement system is activated cascadically via three distinct major routes: classical pathway (CP), alternative pathway (AP) or lectin pathway (LP).
Cedzyński M, Świerzko AS.
europepmc   +5 more sources

The Lectin Pathway of Complement in Myocardial Ischemia/Reperfusion Injury—Review of Its Significance and the Potential Impact of Therapeutic Interference by C1 Esterase Inhibitor

open access: yesFrontiers in Immunology, 2018
Acute myocardial infarction (AMI) remains a leading cause of morbidity and mortality in modern medicine. Early reperfusion accomplished by primary percutaneous coronary intervention is pivotal for reducing myocardial damage in ST elevation AMI.
Marten Trendelenburg   +2 more
exaly   +4 more sources

MAp34 Regulates the Non-specific Cell Immunity of Monocytes/Macrophages and Inhibits the Lectin Pathway of Complement Activation in a Teleost Fish [PDF]

open access: yesFrontiers in Immunology, 2020
The lectin pathway of the complement system is one of the main components of innate immunity, which plays a pivotal role in the defense against infectious microorganisms and maintains immune homeostasis.
Liangliang Mu   +5 more
doaj   +3 more sources

Be on Target: Strategies of Targeting Alternative and Lectin Pathway Components in Complement-Mediated Diseases [PDF]

open access: yesFrontiers in Immunology, 2018
The complement system has moved into the focus of drug development efforts in the last decade, since its inappropriate or uncontrolled activation has been recognized in many diseases.
József Dobó   +2 more
doaj   +3 more sources

Home - About - Disclaimer - Privacy